Related Experiment Video
Updated: Sep 20, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
miRNAs in multiple sclerosis: A clinical approach
Claudia Minutti-Zanella1, Lorena Bojalil-Álvarez2, Elizabeth García-Villaseñor3
1Universidad de las Américas Puebla, San Andrés Cholula, PUE, México; Centro de Hematología y Medicina Interna, Clínica RUIZ, PUE, Méixico.
Abstract:
Micro-RNAs (miRNAs) are noncoding, single stranded segments of RNA measuring 19 to 25 nucleotides in length. They play an active role in autoimmune diseases, including multiple sclerosis (MS). These structures have been studied given their implication in the process of diagnosis, disease development, treatment and prognosis of MS. Given the progressive and neurodegenerative nature of MS, miRNAs have been identified as critical mediators and molecular pinpoints of the disease, which poses them as excellent candidates for the obtention of suitable biomarkers and treatment targets. This review condenses recent findings on the role of miRNAs in multiple sclerosis, including their role in MS etiology and molecular mechanisms of the disease, exploitation of miRNAs as diagnostic tools and biomarkers, miRNAs as treatment option or target for MS, and their significance as predictors of disease prognosis.
Insights
Micro-RNAs (miRNAs) are key players in multiple sclerosis (MS), influencing its development and progression. Research highlights their potential as diagnostic biomarkers and therapeutic targets for this neurodegenerative autoimmune disease.
Area of Science:
- Biochemistry
- Neuroimmunology
- Molecular Biology
Background:
- Multiple sclerosis (MS) is a progressive neurodegenerative autoimmune disease.
- Micro-RNAs (miRNAs) are small noncoding RNA molecules involved in gene regulation.
- miRNAs have emerged as critical mediators in the pathogenesis of MS.
Purpose of the Study:
- To review the current understanding of micro-RNAs (miRNAs) in multiple sclerosis (MS).
- To explore the role of miRNAs in MS etiology, molecular mechanisms, diagnosis, and treatment.
- To assess the potential of miRNAs as biomarkers and therapeutic targets for MS.
Main Methods:
- Literature review of recent findings on miRNAs and MS.
- Analysis of studies investigating miRNA involvement in MS pathogenesis.
- Synthesis of information regarding miRNA-based diagnostics, therapeutics, and prognostics.
Main Results:
- miRNAs are implicated in the molecular mechanisms underlying MS development and progression.
- Specific miRNAs show potential as diagnostic biomarkers for MS.
- miRNAs represent promising targets for novel MS therapeutic strategies.
- miRNA expression levels may predict disease prognosis in MS patients.
Conclusions:
- Micro-RNAs (miRNAs) are significant molecular players in multiple sclerosis (MS).
- miRNAs offer potential as diagnostic tools, therapeutic targets, and prognostic indicators for MS.
- Further research into miRNAs could lead to improved management of multiple sclerosis.
